US Department of Defense funds MediWound’s non-surgical burn treatment

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 02, 2024 at 10:12: PM
via Biotherapeutics company MediWound has secured an additional $6.7 million in funding from the US Department of Defense to advance its non-surgical burn treatment for the US Army.

article source
 

<



Similar threads

cafead
Biosecure Act left out of Department of Defense spending bill by House Rules Committee
Replies
0
Views
30
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Factor Bioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell...
Replies
0
Views
157
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Defense Department backs new study of Idorsia&#039;s Quviviq as a treatment for PTSD
Replies
0
Views
130
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development
Replies
0
Views
95
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
U.S. Department of Defense Awards Moderna $1.97 Billion COVID-19 Vaccine Contract
Replies
0
Views
145
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote